Moderna Competitors and Similar CompaniesClear all

Moderna's competitors and similar companies include Regulus Therapeutics, Alnylam Pharmaceuticals and Celyad.
Moderna
Moderna
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Founding Date
Founding Date
2010
Founding Date
2007
Founding Date
2002
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Melbourne, AU
Paris, FR
München, DE
Tokyo, JP
Seoul, KR
Warszawa, PL
see more
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Employees
Employees
5,60044% increase
Employees
2462% decrease
Employees
1,32324% increase
Employees
35
Valuation ($)
Valuation ($)
40.3 b
Valuation ($)
188.5 m
Valuation ($)
19.2 b
Valuation ($)
15.9 m
Twitter followers
Twitter followers
151.2 k
Twitter followers
790
Twitter followers
16.3 k
Twitter followers
2.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
39.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
86.96%
Percentage of tweets with engagement (last 30 days)
50%

Financial

Revenue (est.)
Revenue (est.)
$6.8b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$4.7b (FY, 2023)
Cost of goods
N/A
Cost of goods
$268.2m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
$2.2b (FY, 2023)
Gross profit
N/A
Gross profit
$1.6b (FY, 2023)
Gross profit
€24.1m (FY, 2022)
Net income
Net income
($4.7b) (FY, 2023)
Net income
($30m) (FY, 2023)
Net income
($440.2m) (FY, 2023)
Net income
(€40.9m) (FY, 2022)

Operating

Patents Issued
Patents Issued
270 (FY, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 1.8b
Total funding raised
$ 10m
Total funding raised
$ 1.5b
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
35

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company